Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

Completed · Not applicable · Has a placebo group

Conditions studied: Schizophrenia

In brief

This study will determine whether eszopiclone will normalize sleep patterns and restore sleep-dependent enhancement of motor skill learning in patients with schizophrenia. The investigators will compare subjects taking a placebo to those taking 3 mg of eszopiclone with regard to: sleep architecture and sleep latency as measured by actigraphy and polysomnography and sleep-dependent motor skill learning.

Key facts

Study ID

NCT00833547

Run by

Massachusetts General Hospital

People needed

25

Starts

2006-09-01

Expected to finish

2012-09-01

Last updated by the study team

2014-09-09

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinically stable outpatients with DSM-IV diagnoses of Schizophrenia

You may not qualify if…

• History of neurologic or psychiatric disease other than schizophrenia
• Substance abuse or dependence within the past six months
• Other chronic medical conditions that affect sleep
• Pregnancy/breast feeding
• Hepatic impairment
• Treatment with metabolic inhibitors or inducers

Where it is running

• Mass General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.